Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05323175 · ClinicalTrials.gov registry record · Phase 4

Erector Spinae Plane (ESP) Block for Renal Colic

A Phase 4 study of Renal Colic, sponsored by Stony Brook University.

Active
Registry status
Phase 4
Development phase
24
Enrollment target
1
Study location

NCT05323175 is a Phase 4 study of Renal Colic that is active but no longer recruiting, run by Stony Brook University. The registered enrollment target is 24 participants, below the 92-participant average among 3 other Renal Colic trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05323175, a Phase 4 study of Renal Colic, is active but no longer recruiting, sponsored by Stony Brook University.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Comparing standard of care to erector spinae plane block for acute renal colic pain.

Conditions Studied

Interventions

  • DRUG Ropivacaine injection
  • OTHER Standard of care medications

Study Locations (1)

New York

  • StonyBrook University Hospital - Stony Brook

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2022-04-25
Est. Completion 2025-06-01
Phase Phase 4

Sponsor

Stony Brook University

127 total trials

What the Registry Record Tells You About NCT05323175

The ClinicalTrials.gov registry entry for NCT05323175 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 3 other Renal Colic trials with a reported enrollment target (74% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Renal Colic appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine injection is the first listed.

NCT05323175 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05323175 about?

NCT05323175 is a clinical study titled "Erector Spinae Plane (ESP) Block for Renal Colic". Comparing standard of care to erector spinae plane block for acute renal colic pain.

What is the current status of trial NCT05323175?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2022-04-25. Estimated completion is 2025-06-01.

What conditions does trial NCT05323175 study?

This clinical trial studies the following conditions: Renal Colic.

What interventions are being tested in trial NCT05323175?

The interventions under investigation include: Ropivacaine injection (DRUG), Standard of care medications (OTHER).

Who is sponsoring clinical trial NCT05323175?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05323175 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Renal Colic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.